The risk for leg and foot amputation is now listed under Warnings and Precautions instead of box warning. 

A new clinical software using artificial intelligence is being used for those with type 2 diabetes in Kentucky. It shows promising results in improving the Quality of Life for its residents and lowering treatment costs. This feature will be a 3-part series. 

In Part 1:  Adherence-related issues are hemorrhaging the costs of diabetes-related treatment in America. To offset this tragedy, GlucosePATH is utilized by a team of healthcare professionals dedicated to improving the quality of life while decreasing avoidable costs.  

Is a very low carbohydrate diet (VLCD) superior to an essential carbohydrate/low-fat diet (LFD) for improving body mass and insulin sensitivity? 

Have the challenges of creating an effective oral insulin finally been overcome?

Cardiovascular events decline for patients using which antidiabetic medication?

Can improving diabetes care be as simple as ensuring patients receive regular testing?

Data from the REWIND trial suggest that dulaglutide has cardioprotective properties. 

The combination of an SGLT2i plus a GLP-1 RA results in surprising effects on endogenous glucose production and HBA1c. 

Care of the elderly can be very challenging. Can adding yet another medication actually help?   

Is the risk as substantial as was initially reported?